Table 1.
Autors (Year) (Type) | n | M/F | Age | Body fluid measured | Memory | Attetion | Executive Functions | Visuospatial abilities and psychomotor | Perception | Inteligence | Global Cognition | Neuropsychocological Assement Instruments | Result | Methodological aspects | Ref |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chua et al (2014)34 (longitudinal study) | 218 PMW | 0/218 | 59,7 | Blood samples | X | A comprehensive battery of 13-item neuropsychological tests. | The analyses demonstrated no significant relation between DHEAS level and cognitive function in midlife, postmenopausal women. |
|
[34] | ||||||
Merritt et al (2012)38 (longitudinal study) | 48 PMW | 0/48 | 63,5 +/- 6,85 | * | x |
|
Despite this substantial change in the hormonal milieu, DHEA administration produced no beneficial effects on cognitive performance in the digit span, verbal span, or modified Sternberg paradigm tasks. |
|
[38] | ||||||
Fukai et al (2009)23 (cross-sectional study) | 208 EFD | 108 / 100 | 70 – 95 Years (M) 70 – 93 Years (W) | Blood samples | x |
|
Only in men DHEA(-S) was associated with cognitive function. |
|
[23] | ||||||
Alfaro et al (2008)5 (cross-sectional study) | 313 E | 153 / 160 | 76,7 +/- 5,4 (M) 77,3 +/- 6,4 (W) | Blood samples | x | x |
Examination (MMSE) |
In women, adrenal steroids showed a negative correlation with global cognition. For memory function, DHEA also correlated negatively in women. No relationships with cognition were observed in men for any of the steroids. |
|
[5] | |||||
Kritz-Silverstein et al (2008)39 (longitudinal survey) | 112 DT 113 P | 110 / 115 | 68,7 +/- 7,9 | Blood samples | x | x |
|
There were no differences between the DHEA and placebo groups in change over time in cognitive function (P>.10). DHEA supplementation has no benefit on cognitive performance in healthy older adults, and it should not be recommended for that purpose in the general population. |
|
[39] | |||||
Davis et al (2008)32 (cross-sectional study) | 295 W | 0/295 | 55 +/- 12,8 | Blood samples | x | x | x |
|
DHEAS term made a significant independent Positive contribution to the Controlled Oral Word Association Test score, a measure of executive function. In addition, women with a DHEAS level in the highest tertile who also had more than 12 yr of education performed better on both Digit Span Forward and Digit Span Backward tests, which are tests of simple concentration and working memory, respectively. |
|
[32] | ||||
Kędziora-Kornatowska et al (2007)27 (cross-sectional study) | 103 EHW 25C | 0/128 | 70,7 +/- 7,3 | Blood samples | x |
|
Statistically significantly lower DHEA-S concentration was observed in patients with benign disorders of cognitive functions and depression compared with patients with correct MMSE |
|
[27] | ||||||
Haren et al (2007)6 (cross-sectional study) | 124 EHM | 124/0 | 56,1 +/- 4,4 | Blood samples | x |
|
Higher DHEAS levels were associated with higher mini-mental state examination (MMSE) score (b =0.098, p= 0.008). |
|
[6] | ||||||
Goldman e Glei (2007)22 (longitudinal survey) | 836 E | * | 54 and older | Blood samples | x | Items from:
|
In most men low levels of DHEAS are associated with poor cognitive function . There are no significant associations among women. |
|
[22] | ||||||
Arai et al (2006)26 (cross-sectional) | 145 E | 58/87 | 75,6 +/- 0.56 | Blood samples | x |
|
The levels of DHEA e DHEA-S were not associated with MMSE. |
|
[26] | ||||||
Parsons et al (2006)29 (longitudinal survey) | 11 DT 9P | 0/20 PMW | 46-66 years | Blood samples | x |
Test (CVLT)
Stroop Test
Nonverbal Intelligence-2 (TONI-2)
|
An increase in negative associations between DHEA(S) levels and cognition was found at completion. Increased cortisol does not explain the cognitive deficits associated with DHEA, suggesting a direct negative effect of exogenous DHEA on cognition. |
|
[29] | ||||||
Alhaj et al (2006)36 (longitudinal survey) | 24 YM | 24/0 | 23,6 +/- 5,1 | Saliva samples | x |
|
DHEA administration led to a reduction in evening cortisol concentrations and improved VAS mood and memory. Recollection accuracy in the episodic memory test was significantly improved following DHEA administration. |
|
[36] | ||||||
Azurmendi et al (2005)41 (cross-sectional) | 129 C | 60/69 | 5 years 11 months mean age | Saliva samples | x |
|
DHEA was not a good predictor for fluid intelligence and crystallized intelligence in both genders. |
|
[41] | ||||||
Fonda et al (2005)9 (cross-sectional) | 981 EHM | 981/0 | 62,66 years | Blood samples | x | x | x |
|
The direct effects of hormones on cognition are not significant when salient factors (educational attainment, health conditions and behaviors, body mass index, and depression) are considered. |
|
[9] | ||||
Glei et al (2004)21 (cross-sectional) | 967 E | * | 54 and older | Blood and urine samples | x |
modified Short Portable Mental Status Questionnaire
Test
Backward test. |
Results reveal that higher levels of DHEAS are associated with better cognitive function (among women but not men) |
|
[21] | ||||||
Hirshman et al (2004)37 (longitudinal study) | 6 PMW | 0/6 | 53-68 years | Blood samples | x | x | x |
|
Our results demonstrated that estrogens produced a positive effect on recognition memory and perceptual identification, while androgens produced a negative effect. Androgens also produced a negative effect on visual attentional vigilance. |
|
[37] | ||||
Nierkerk et al (2001)34 (longitudinal study) | 46 (EM) | 46/0 | 62-76 years | Saliva samples | x |
|
A higher morning cortisol/DHEA ratio was also associated with lower visuo-spatial memory performance. But no significant effects of DHEA treatment were observed on any of the trial outcomes. |
|
[34] | ||||||
Aleman et al (2001)33 (cross-sectional) | 25 EHM | 25/0 | 69,1 years | Blood samples | x | x |
Judgement of Line Orientation
|
Circulating levels of DHEAS were not associated with any of the neuropsychological measures. |
|
[33] | |||||
Moffat et al (2000)7 (longitudinal study) | 883 EHM | 883/0 | 22-91 years | Blood samples | x |
|
Decline in endogenous DHEAS concentration is independent of cognitive status and cognitive decline in healthy aging men. |
|
[7] | ||||||
Carlson and Sherwin (1999)25 (longitudinal study) | 60 E | 23/37 | 72.1 and 73.4 years | Blood samples | x |
Memory Scale (WMS)
Recall
Figural Memory
subtests
|
Results failed to provide any evidence that DHEAS is protective against declarative memory decline with aging. |
|
[25] | ||||||
Kalmijn et al (1998)28 (longitudinal study) | 189 E | * | 67.3 +/- 5.7 | Blood samples | x |
|
There was an inverse, but nonsignificant, association between DHEAS and cognitive impairment and decline. |
|
[28] | ||||||
Yaffer et al (1998)8 (longitudinal study) | 394 EHW | 0/394 | 65 and older | Blood samples | x |
|
DHEAS levels declined with age, as expected. There was no consistent association of DHEAS quartile or log DHEAS with any of the four outcomes, even after multivariate adjustment. |
|
[8] | ||||||
Carlson and Sherwin (1998)24 (cross-sectional study) | 86 E | 41/55 | 72.19+/-5.6 years | Blood samples | x |
Recall
subtests
|
No significant correlations were found between any of the hormones or the DHEAS/CRT ratio and scores on any of the neuropsychological tests. |
|
[24] | ||||||
Wolf et all (1998)35 (longitudinal study) | 17 E | 17/0 | 71.1 ± 1.7 years | Blood samples | x |
|
DHEA treatment did not enhance memory |
|
[35] | ||||||
Wolf et al (1997)40 (longitudinal study) | 40 E | 25/15 | 69,4 +/- 1,2 (M) 69,1 +/- 1,7 (W) | Blood samples | x | x | x |
|
DHEA replacement had no strong beneficial effect on any of the measured psychological or cognitive parameters in either sex (all P. 0.20). |
|
[40] |
Legend: DP – Depressed Pacients; C – Controls; PMW – Postmenopausal women; EFD – Eldery with Functional Decline; E – Eldery; M- Men; W – Women; EHW – Eldery Healthy Women; YM – Young Men; EHM – Eldery Healthy Men; P – Placebo; DT – DHEA Treatment; *unspecified.